C0220825||evaluation
C0298067||pirfenidone
C3872815||combined pulmonary fibrosis emphysema syndrome
C3872815||combined pulmonary fibrosis emphysema syndrome
C3872815||combined pulmonary fibrosis emphysema syndrome
C0278252||poor prognosis
C1446409||positive
C0298067||pirfenidone
C0298067||pirfenidone
C3872815||combined pulmonary fibrosis emphysema syndrome
C0220825||evaluate
C0298067||pirfenidone
C0087111||treatment
C3872815||combined pulmonary fibrosis emphysema syndrome
C0425542||adventitious lung sounds
C0425542||discontinuous adventitious lung sounds
C0034642||crackles
C0442726||detect
C0748168||pulmonary pathologies
C1710191||analysis
C0035234||LS
C0425542||discontinuous adventitious lung sounds
C0009085||clusters
C0002045||kmeans
C0009085||clusters
C0425542||discontinuous adventitious lung sounds
C0425542||discontinuous adventitious lung sounds
C0220825||evaluation
C0298067||pirfenidone
C0425542||discontinuous adventitious lung sounds
C0037775||spatial distribution
C0425542||discontinuous adventitious lung sounds
C3872815||combined pulmonary fibrosis emphysema syndrome
C0087111||treatment
C0220825||evaluation
C0298067||pirfenidone
C0087111||treatment
C3872815||combined pulmonary fibrosis emphysema syndrome
C0220825||evaluation